Synapse Open Synapse
Biology

Chinese biotech competition and the payer squeeze are reshaping European biotech

Labiotech.eu · · 5 min read

At BIO-Europe last week one preclinical company explained how it was building its drug development program with a focus on fitting prescribing and reimbursement models.

Latest from Labiotech.eu